Comment: cost-effectiveness methodology
Drug Intell Clin Pharm
.
1988 May;22(5):428-9.
doi: 10.1177/106002808802200518.
Authors
G Oster
,
T E Delea
PMID:
3134185
DOI:
10.1177/106002808802200518
No abstract available
Publication types
Letter
MeSH terms
Cost-Benefit Analysis / methods*
Drug Therapy / economics*